• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Submissions
  • About Us
  • Contact Us
  • Feb 2, 2023
  • Startup
    • Creating a Plan
    • Funding a Startup
    • Franchise Center
    • Getting Your Office Ready
    • Making Your Business Official
    • Marketing Your New Business
    • Personal Readiness
  • Run & Grow
    • Customer Service
    • Human Resources
    • Innovation
    • Legal
    • Operations
    • Risk Management
  • Leadership
    • Best Practices
    • Communication
    • Green Initiatives
    • Open Culture
    • Strategic Planning
    • People Skills
  • Sales & Marketing
    • Advertising and Lead Generation
    • Marketing Innovations
    • Marketing Plans
    • Online Marketing
    • Relationships
    • Sales Activities
  • Finance
    • Budgeting and Personal Finance
    • Payments and Collections
    • Tax and Accounting
    • Pricing Strategy
    • Working with Investors
    • Working with Lenders
  • Tech
    • eCommerce
    • Hardware
    • Software
    • Security
    • Tech Reviews
    • Telecom
  • Shop

SmallBizClub

Helping You Succeed

taxbandits banner
Home / Leadership / Closing the Gap in American Vaccine Confidence
Closing the Gap in American Vaccine Confidence

Closing the Gap in American Vaccine Confidence

1344 Views

May 28, 2021 By Brian Wallace

Real Chemistry has been tracking vaccine confidence in the American population since November of 2020.  Through their proprietary social and digital analytics along with global polling, they correlated self-reported vaccine confidence data from social media with consumer data among 5,125 research participants.  They conducted their study in February of 2021, drawing various conclusions about vaccine hesitancy and common attributes associated with this ambivalence. 

Vaccine confidence is holding firm, but it has reached a plateau.  Approximately 10-15% of the US population needs to change their mind to achieve herd immunity, which exists at 70-85% of the population.  Looking at the attributes of Americans who are hesitant to receive a vaccine, they saw that living in a small town, having right-leaning ideologies, or being Black/African American is not the reason why these groups are less willing to receive a COVID-19 vaccine.  Instead, they discovered underlying factors that are common in these three groups, as well as many other United States citizens. 

Real Chemistry has determined the top consumer attributes associated with vaccine confidence and vaccine ambivalence.  Those who support the vaccine often make charitable donations, save a large portion of their income, purchase gourmet foods, have high cholesterol, and live in an area with a high number of individuals with STEM degrees.  Attributes associated with vaccine ambivalence include those who likely read the bible, have multiple pets, spend a high proportion of their income on consumer goods, and live in an area where populations take career advancement courses. 

Vaccine rates by political affiliation, geography, and race remain high with the subtle difference among segments.  However, they did see a slower increase among the right-leaning political affiliation.  Likelihood to vaccinate based on geography ranges from 90-93% between rural and urban communities, and among races, it varies from 88-94%.  Between the apolitical, educated left, and the mainstream left, the likelihood to vaccinate ranges from 89-95%.  The right trails a little behind, with only 65% of their population being likely to vaccinate.  Even so, belief in vaccine safety is high among all political affiliations, as is the belief that we can achieve broad immunity.

Their research shows that race, geography, and political affiliation are not demographic characteristics determining who is willing to vaccinate, except for the right-leaning political group, where a slight gap remains.  Closing the gap will require positive dialogue, vaccine incentives, and convenience.  Refraining from pointing fingers at the right-leaning political party will be more successful in converting citizens, as is reinforcing freedom of choice.  Governments and companies should experiment with incentives that resonate with vaccine-hesitant citizens.  Additionally, the transition from mass vaccination sites to dose availability within local offices and clinics will provide greater access. 

Vaccine Confidence
Via: realchemistry.com

Filed Under: Leadership Tagged With: COVID-19

Brian Wallace

Brian Wallace

Brian Wallace is the Founder and President of NowSourcing, an industry leading infographic design agency based in Louisville, KY and Cincinnati, OH which works with companies that range from startups to Fortune 500s. Brian also runs #LinkedInLocal events nationwide, hosts the Next Action Podcast, and has been named a Google Small Business Advisor for 2016-2018.

Related Posts

  • spring-cleaning-for-a-stress-free-officeThe Science Behind Disinfecting & Sanitizing the Office During COVID
  • This is How to Get People Back in the Office Safely
  • Navigating COVID-19 With Change Management Techniques

Primary Sidebar

Random

10-entrepreneur-milestones-that-make-funding-easy

How Funding Data Can Improve Investor Outcomes

Feb 2, 2023 By SmallBizClub

two-key-digital-innovations-for-small-business

What Can You Do to Give Your Business a Boost?

Feb 2, 2023 By Charlotte Sylvester

5 Tips for Self-Financing Your Startup

Feb 1, 2023 By Lending Tree

Best Places to Buy Property in Portugal: Quick Overview

Feb 1, 2023 By SmallBizClub

4-services-you-need-when-moving-into-a-new-office

Key Factors in Choosing a Real Estate Agent to Sell Your Property

Jan 31, 2023 By SmallBizClub

Footer

About Us

Small Biz Club is the premier destination for small business owners and entrepreneurs. To succeed in business, you have to constantly learn about new things, evaluate what you’re doing, and look for ways to improve—that’s what we’re here to help you do.

  • Facebook
  • LinkedIn
  • RSS
  • Twitter

Copyright © 2023 by Tarkenton Institute, Inc. All Rights Reserved | Terms | Privacy